Cannabis Science & Health
Colorado Votes to Decriminalize Most Psychedelics and Regulate Psilocybin Therapy
Once enacted, the proposal will give any adult in the state, aged 21 and over, the legal right to possess, use, cultivate and share psilocybin, ibogaine, mescaline (not derived from peyote), DMT, and psilocyn without fear of arrest.
Cannabis Consumption Rose in Medical-Only States During the Pandemic, Study Finds
Based on these findings, the researchers theorize that more restrictive frameworks for cannabis use may not be effective at preventing use during times of great stress.
US States Need More Delta-8 Regulations, Researchers Argue
The delta-8 market urgently needs more oversight and higher safety standards, according to a new viewpoint letter.
Microdosing LSD Boosts the Brain’s Reward System, Study Finds
A new study has found that a single microdose of LSD can increase brain activity related to its reward system.
Psilocybin and Psychotherapy Relieve Treatment-Resistant Depression in Largest Clinical Trial to Date
The largest study to date testing the ability of the psychedelic compound psilocybin to treat a psychiatric disorder has shown that the mushroom-derived drug, delivered in combination with integrative psychotherapy sessions, significantly reduced participants’ depression as compared to a placebo after three weeks.
Just One Question Can Help Clinicians Screen for Cannabis Use Disorder, Study Claims
If you need to quickly assess whether a patient might have cannabis use disorder, ask them how often they’ve used cannabis in the past year. At least, that is the suggestion put forward in new research published this week.
Cannabis Holds Promise For Pain Management, Reducing The Need For Opioid Painkillers – A Neurology Expert Explains How
Writing in the Conversation, Benjamin Land, a research associate professor of pharmacology at the University of Washington, explains how cannabis could be used as an opioid substitute.
AOAC Grants Its First ‘Reviewed and Recognized’ Certificate For Cannabis Potency Testing
The certificate was awarded on October 20 to Viridis Laboratories, a cannabis lab in Michigan.
New York Cannabis Regulator Removes Yeast and Mold Testing Requirement
The state’s Office of Cannabis Management has removed the pass/fail limits associated with the total yeast and mold counts for cannabis flower and pre-rolls.
What the Cannabis Industry Needs to Know About Novel Synthetic Cannabinoids
Chris Hudalla, president and chief scientific officer at ProVerde Laboratories, explores the legality and implications of novel synthetic cannabinoids.
